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The phosphoinositide phosphatidylinositol 4,5-bisphosphate [PI(4,5)P2] regulates the activity of many
actin-binding proteins and as such is an important modulator of cytoskeleton organization during cell
migration, for example. In migrating cells actin remodeling is tightly regulated and localized; therefore, how
the PI(4,5)P2 level is spatially and temporally regulated is crucial to understanding how it controls cell
migration. Here we show that the LIM protein Ajuba contributes to the cellular regulation of PI(4,5)P2 levels
by interacting with and activating the enzymatic activity of the PI(4)P 5-kinase (PIPKI), the predominant
enzyme in the synthesis of PI(4,5)P2, in a migration stimulus-regulated manner. In migrating primary mouse
embryonic fibroblasts (MEFs) from Ajuba/ mice the level of PI(4,5)P2 was decreased with a corresponding
increase in the level of the substrate PI(4)P. Reintroduction of Ajuba into these cells normalized PI(4,5)P2
levels. Localization of PI(4,5)P2 synthesis and PIPKI in the leading lamellipodia and membrane ruffles,
respectively, of migrating Ajuba/ MEFs was impaired. In vitro, Ajuba dramatically activated the enzymatic
activity of PIPKI while inhibiting the activity of PIPKII. Thus, in addition to its effects upon Rac activity
Ajuba can also influence cell migration through regulation of PI(4,5)P2 synthesis through direct activation of
PIPKI enzyme activity.
The phosphoinositide phosphatidylinositol 4,5-bisphosphate
[PI(4,5)P2] is an important regulator of cytoskeletal organiza-
tion during diverse cellular functions such as vesicle trafficking,
endocytosis, phagocytosis, focal adhesion formation, and cell
migration. PI(4,5)P2 binds to and affects the function of many
actin-binding and actin-remodeling proteins such as profilin,
gelsolin, vinculin, talin, cofilin, -actinin, WASP, Arp2/3, and
the Rho family of GTPases (for reviews see references 2, 14,
and 28). In general PI(4,5)P2 production is concentrated at the
plasma membrane, and the total cell amount is maintained at
a relatively constant level; however, localized dynamic changes
have been observed in response to growth factor stimulation
and cell adhesion to the extracellular matrix, at sites of phago-
cytosis, and in actin-rich protrusion and membrane ruffles (3, 6,
8). How the PI(4,5)P2 level is spatially and temporally regu-
lated is therefore crucial to understanding the cellular re-
sponses that it controls.
The synthesis of PI(4,5)P2 is regulated by a family of en-
zymes, phosphatidylinositol phosphate kinases (PIPKs) (re-
viewed in reference 14). The PIPKs can be subdivided into
three subfamilies, types I, II, and III, based on their substrate
specificity and the position that they phosphorylate on the
inositol ring. For type I and II there are , , and  isoforms of
each that have been identified and characterized biochemi-
cally. Recently a new PIPK type I homolog, PIPKH, has been
identified, and it appears to localize and regulate other type I
kinases but has little kinase activity itself (7). PIP kinases
comprising type I utilize PI(4)P as substrate and phosphorylate
the D5 position of the inositol ring, while the substrate for type
II kinases is PI(5)P and the enzymes phosphorylate the D4
position of the inositol ring. Type III PIPK, PIPfyve, utilizes
PI(3)P as substrate and produces PI(3,5)P2 (37). Type I and II
kinases can also utilize PI(3)P but with much-reduced effi-
ciency (41, 45). Since PI(4)P is the major phosphatidylinositol
phosphate in cells and its concentration is relatively high, type
I PIPKs are thought to play a more prominent role in the
production of PI(4,5)P2.
The subcellular localization of these enzyme families also
differs. Many of the early studies were done in cells overex-
pressing tagged forms of the enzymes; however, recently new
antibodies have allowed for the localization of endogenous
enzymes (13, 15, 26). In fibroblasts type I PIPK is found at
membrane ruffles, diffusely throughout the cytosol, and within
the nucleus. Type I is primarily present on perinuclear cyto-
solic vesicular structures, and type I is found at focal adhe-
sions. Type II enzymes are present in the cytosol and nucleus
and associated with the endoplasmic reticulum. Type III en-
zymes contain a FYVE motif that targets them to endomem-
branes, where the production of PI(3,5)P2 regulates mem-
brane integrity (21, 36).
The generation of PI(4,5)P2 at specific subcellular sites of
cytoskeletal rearrangement is most likely modulated by selec-
tive targeting and activation of specific PIPKs. For example,
PIPKI is targeted to sites of focal adhesions through an in-
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teraction with the focal adhesion protein talin, and this asso-
ciation also results in an increase of the kinase activity of the
enzyme (13, 26). The localized generation of PI(4,5)P2 by
PIPKI at focal adhesions appears to be critical for the for-
mation of focal complexes and their maturation to focal adhe-
sions (13, 26). PIPKI localizes to membranes in response to
G-protein-coupled receptor activation (8) and to membrane
ruffles in response to platelet-derived growth factor stimulation
(15). Finally in B cells the BTK kinase associates with PIPKI
and, in response to B-cell receptor signaling, brings PIPKI to
membranes to generate local synthesis of PI(4,5)P2 (35).
The Rho family of G proteins are major regulators of actin
cytoskeletal dynamics (17). RhoA activity regulates the forma-
tion of stress fibers and focal adhesions, while Rac1 regulates
lamellipodium production and membrane ruffling. Regulated
formation and turnover of these structures are important dur-
ing cell migration. To effect actin assembly, Rho family pro-
teins require PI(4,5)P2 synthesis (31). Rho, Rac, and another
G protein, Arf6, have all been shown to regulate PIPK activity
(20, 40, 43), and some PIPKs can associate with Rac and Rho,
in vitro (34, 38, 39). Rac can also activate phosphatidylinositol
4-kinase, an enzyme that leads to the production of PI(4)P, the
major cellular substrate for PIPKs (44). Recently we have
shown that the focal adhesion LIM protein Ajuba affects cell
migration by influencing the localization of p130Cas to nascent
focal complexes and thus Rac1 activity through the efficient
assembly of the p130Cas/Crk/DOCK180/ELMO Rac GEF
(32).
Ajuba is a cytosolic protein and a member of the zyxin/Ajuba
family of LIM proteins (4, 5), defined by the presence of three
related tandem LIM domains at the C termini (LIM region)
and unrelated, proline-rich N termini (PreLIM region). These
proteins are components of integrin-mediated adhesive com-
plexes in fibroblasts (5, 32) and cell-cell junction adhesive
complexes in epithelial cells (19, 27) and interact with filamen-
tous actin either indirectly or directly (11, 27). Thus, in addi-
tion to regulating cell migration, they contribute to the forma-
tion or strengthening of cell-cell junctions in part by linking
adhesive receptors to the actin cytoskeleton (27). This family
of LIM proteins also contains nuclear export signals, and the
proteins shuttle in and out of the nucleus, suggesting that they
could function to transduce signals from cell adhesive sites to
the nucleus (1, 23, 29, 30). Indeed Ajuba was recently shown to
interact with and affect the activity of the mitotic kinase Au-
rora A (18).
To further understand how Ajuba regulates actin dynamics,
and cell migration specifically, we performed a yeast two-hy-
brid protein-protein interactive screen to identify potential
Ajuba-interacting proteins implicated in cytoskeletal regula-
tion. We found that Ajuba associates with the PIPK enzymes
PIPKI and PIPKII and affects their subcellular localization
and enzyme activity. Ajuba/ primary MEFs have reduced
levels of PI(4,5)P2 and a corresponding elevation of the sub-
strate PI(4)P. PI(4,5)P2 levels are corrected upon reintroduc-
tion of Ajuba into these cells. These results suggest that in
addition to regulating Rac activity Ajuba could also influence
cell migration by regulating the levels of cellular PI(4,5)P2
through a direct interaction with and activation of PIPKI.
MATERIALS AND METHODS
Yeast two-hybrid screen. The PreLIM region of human Ajuba was subcloned
into the pAS2 plasmid and sequenced. Parental AH109 yeast cells (Clontech)
were transformed, and production of Gal4-PreLIM-Ajuba fusion protein in yeast
was confirmed by Western blotting using purified Ajuba antibody. Competent
yeast cells containing pAS2-PreLIM were then transformed with a human ker-
atinocyte Matchmaker cDNA library (Clontech). Transformants (5  106) were
screened. Twenty primary positives were identified. Colonies were cured of the
bait plasmid by segregation, and the remaining library plasmid was rescued by
transforming XL1-Blue bacteria. Retransformation of AH109 yeast cells with
appropriate specificity controls was carried out. Of the 20 primary positives 5
persisted as true positives. All were sequenced, and two clones contained partial
sequence for PIPKII.
Plasmid construction, antibodies, and cell lines. The cDNAs of PIPKI and
- and PIPKII and - isoforms were PCR amplified from a human keratinocyte
cDNA library. PIPKI661 was from R. Anderson (University of Wisconsin) (26).
All PCR products were subcloned into pCMV5-HA and sequenced. Myc-tagged
Ajuba, zyxin, and LPP plasmids have been described elsewhere (16, 23). Anti-
hemagglutinin (anti-HA) antibodies conjugated to agarose (Santa Cruz) or
M2AG (Sigma), polyclonal Myc antiserum, and Ajuba antiserum have been
described previously (16, 27). PIPKI antiserum has been described in reference
15. Littermate Ajuba-null and wild-type (wt) MEFs were generated as described
previously (32). Primary MEFs within the first 12 passages were transfected using
the Nucleofector MEF2 kit (Amaxa, Inc., Gaithersburg, MD). HEK 293 cells
were transfected using Trans-IT LT-1 (Mirrus, Madison, WI). All cells were
maintained in Dulbecco modified Eagle medium supplemented with 10% fetal
calf serum.
Immunoprecipitation. HEK 293 cells (4  105/well) were plated in a 12-well
plate overnight before transfection. Cells were transfected and 24 h later col-
lected and lysed with IP buffer (20 mM HEPES, pH 7.5, 120 mM NaCl, 5 mM
NaF, 1 mM sodium orthovanadate, 0.5 mM EDTA, 1 mM dithiothreitol, 5%
glycerol, 0.1% NP-40, protease inhibitors), and cytoplasmic extract was clarified
by spinning at 12,000 rpm for 10 min and mixed with primary antibodies over-
night. Beads were washed with IP buffer five times, and bound products were
eluted with 20 l of sodium dodecyl sulfate (SDS)-polyacrylamide gel loading
buffer. Five microliters was loaded per lane and separated on a 10% SDS-
polyacrylamide gel, under reducing conditions, and transferred to nitrocellulose
membranes for Western blot analysis.
wt, Ajuba-null, and Ajuba-null MEFs rescued with Flag-tagged Ajuba were
grown to confluency. To stimulate migration, half of the plates were scratch
wounded multiple times such that 50% of cells were removed. Stimulated and
unstimulated cells were harvested and lysed 1.5 to 2 h postwounding. Flag
immunoprecipitation was performed as above. Bound material was eluted from
the beads with 100 g/ml Flag peptide. Eluted proteins from the same immu-
noprecipitate were analyzed by both Western blotting and in vitro lipid kinase
assay.
Protein purification. His-tagged PIPKI and PIPKII were purified as de-
scribed previously (45). PIPKI and PIPKII were subcloned into a pBacPAK9
plasmid (Clontech) containing a His6 and Flag tag fragment between the BamHI
and EcoRI sites. The kinases were expressed in Sf9 cells. For protein purifica-
tion, crude kinase extracts were loaded onto 1 ml Talon metal affinity columns
(Clontech) equilibrated with high-salt buffer (1 phosphate-buffered saline con-
taining 650 mM NaCl). The column was washed thoroughly with 50 ml of
high-salt buffer, and then proteins were eluted with a 30 ml linear gradient of 0
to 100 mM imidazole in high-salt buffer. Fractions containing purified kinase
were combined and concentrated with Centricon-10 concentrators (Amicon) and
dialyzed overnight against 50 mM Tris, pH 7.6, 1 mM EGTA, 10% glycerol (for
PIPKI, 150 mM NaCl was also present in the dialyzing buffer). The PreLIM
region of Ajuba was expressed and purified from bacterial extracts on glutathi-
one-agarose beads, as a glutathione S-transferase (GST)–PreLIM fusion protein.
The PreLIM peptide was cleaved from the GST moiety with Prescission protease
(Amersham), and the released peptide was dialyzed overnight.
Lamellipodium purification. Lamellipodium purification was performed as
described previously (9, 32). Briefly, MEFs were serum starved overnight and
then plated in the upper chamber of wells containing a 3.0-m porous Transwell
filter (Fisher Co., Pittsburgh, PA) coated on both sides with fibronectin (5 mg/ml
fibronectin [Sigma] in phosphate-buffered saline). Cells were allowed to attach
and spread for 2 h. Lamellipodium formation was induced by the addition of
serum to the bottom chamber. Cell bodies or lamellipodia were isolated after 60
to 90 min from the top or the bottom of the membrane, respectively, into lysis
buffer (20 mM HEPES, pH 7.5, 100 mM NaCl, 0.5 mM EDTA, 1 mM NaF, 1
mM sodium orthovanadate, 0.1% NP-40, and protease inhibitors).
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Lipid kinase assay. Lipid kinase activity assays were carried out for 10 min
(unless indicated otherwise) at 37°C in 50-l reaction volumes containing 50 mM
Tris, pH 7.6, 10 mM MgCl2, 0.5 mM EGTA, 20 M PIP substrate (prepared in
isotonic KCl solution), and 50 M [32P]ATP (5 Ci/reaction). The reactions
were stopped by the addition of 100 l of 1 N HCl, and the lipid products were
extracted using 200 l of chloroform-methanol (1:1). The organic phase was
washed with 100 l of methanol-1 N HCl (1:1). The organic phase was then
spotted on thin-layer chromatography (TLC) plates and run as described previ-
ously (45). After autoradiography, the spots on the TLC plates corresponding to
products were scraped into vials and counted using Cerenkov radioactivity in a
Beckman scintillation counter.
Determination of inositol phospholipid levels. MEFs were incubated in phos-
phate-free Dulbecco’s modified Eagle’s medium (Invitrogen) containing 400 Ci
of [32P]orthophosphate (ICN) for 2 h at 37°C. For phosphoinositide isolation
from lamellipodia or cell bodies, MEFs were labeled while adhering to the filter
in the upper chamber of the Transwell (see above). Lipids were extracted by an
addition of 0.5 ml methanol:chloroform:8% HClO4 (20:10:1). Phosphoinositide
deacylation and separation on an anion-exchange column were done as described
before (24).
Live cell imaging. Live cell imaging was performed on cells grown on the glass
coverslips as described previously (42). Following transfection, cells were grown
to 100% confluence, scratch wounded, and placed in a heated chamber (Delta T
from Bioptechs, Butler, PA) containing L-15 medium plus 10% fetal calf serum.
Images were taken using an upright BX61WI microscope (Olympus), a xenon
illumination source (Lambda LS; Sutter Instruments, San Rafael, CA), and a
water-immersion lens (0.9 numerical aperture) with a cooled charge-coupled
device camera (Coolsnap HQ; Roper Scientific) and processed using Metamorph
software (Universal Imaging, Media, PA).
Interfering RNA (RNAi) knockdown of PIPKI. Lentiviruses expressing
PIPKI-specific small interfering RNA (siRNA) or control scrambled siRNA
were generated (33). These viruses also contain an internal ribosome entry
site-green fluorescent protein (GFP) cassette. The PIPKI target sequence was
amino acids 71 to 77 (AAGGTGCCATCCAGTTAGGCA). wt MEFs were
infected, and GFP expression was determined. Plates were lysed, and PIPKI
protein levels were determined by Western blotting.
RESULTS
Ajuba associates with PIPKI and PIPKII in a migration
stimulus-regulated manner. To further understand how Ajuba
influences actin cytoskeleton dynamics, particularly in migrat-
ing cells, we performed a yeast two-hybrid protein-protein in-
teractive screen to identify candidate interacting proteins with
these capabilities. Since skin keratinocytes express high levels
of Ajuba and keratinocytes from Ajuba/ mice are defective
in cell-cell adhesion (27), we screened a human keratinocyte
library with the N-terminal PreLIM region of Ajuba (directing
association with F-actin [27]). In this screen the PIP kinase
PIPKII was one such candidate protein identified.
To confirm that the interaction between Ajuba and PIPKII
occurred in mammalian cells, we carried out coimmunopre-
cipitation experiments. We also determined whether other PIP
kinase enzymes interacted with Ajuba and if there was speci-
ficity among Ajuba family members for interacting with PIPKs.
HEK 293 cells were transiently transfected with various HA-
tagged PIPKs and Flag-tagged full-length Ajuba, the N-termi-
nal PreLIM region of Ajuba, or the C-terminal LIM region of
Ajuba. From cell extracts the Ajuba isoforms were immuno-
precipitated with an anti-Flag antibody, and the presence of
PIPK in the immunoprecipitate was determined by Western
blotting with anti-HA antibodies. In this analysis Ajuba was
found to interact with PIPKII, PIPKI, and PIPKI but not
PIPKII or PIPKI (Fig. 1A to C). For PIPKI and PIPKI
the PreLIM region of Ajuba directed its association (the LIM
region did not interact) (Fig. 1A); however, for PIPKII both
the PreLIM and LIM regions were able to associate with the
enzyme (Fig. 1B). Therefore, while Ajuba interacted with more
than one member of the PIPK enzyme family, there was spec-
ificity, as closely related PIPKII and PIPKI enzymes did not
interact.
To determine whether there was specificity within the Ajuba
family of LIM proteins for interacting with PIPKs, we tested
whether the related LIM proteins zyxin and LPP interacted
with the various PIPKs. HEK 293 cells were transiently trans-
fected with HA-tagged PIPKs and Myc-tagged zyxin or LPP.
PIPKs were immunoprecipitated with anti-HA antibody, and
bound products were Western blotted for the presence of zyxin
and LPP with anti-Myc antibody. Neither zyxin nor LPP inter-
acted with any of the PIPKs (Fig. 1D). Thus, Ajuba’s interac-
tion with PIPKI, PIPKI, and PIPKII was specific among
related LIM protein family members.
To determine whether PIPKs associated with endogenous
Ajuba in cells, we first immunoprecipitated Ajuba from wt
MEFs, Ajuba-null MEFs (negative control), and Ajuba-null
MEFs that had been rescued with Flag-tagged Ajuba. Ajuba-
rescued null MEFs expressed approximately 5- to 10-fold more
Ajuba than what was present in wt MEFs (Fig. 2A). Cells were
either growing at steady state or stimulated to migrate by
performance of multiple scratch-wound procedures in a con-
fluent plate of cells, such that approximately 50% of cells were
removed (32). After 1.5 to 2 hours, a time at which cells had
begun to migrate into the wounds, cells were lysed and Ajuba
was immunoprecipitated. An aliquot of each immunoprecipi-
tated product was subjected to both in vitro PIP kinase assays
(Fig. 2B) and Western blotting for the presence of PIPKI
(Fig. 2A).
PIPKI Western blots of Ajuba immunoprecipitates from
cells growing at steady state detected a small amount of en-
zyme associated with Ajuba (Fig. 2A, left panel). When cells
had been stimulated to migrate, the amount of PIPKI asso-
ciated with Ajuba greatly increased (Fig. 2A, right panel). The
ratio of PIPKI to Ajuba in Ajuba immunoprecipitates was
0.07 in cells at steady state and increased to 0.4 in cells stim-
ulated to migrate (Fig. 2A).
PIP kinase assays were performed in the presence of [32P]ATP
and either PI(4)P (PIPK type I substrate; Fig. 2B) or PI(5)P
(PIPK type II substrate; data not shown) as substrate. The
reaction products were separated on TLC plates, scraped,
deacylated, and identified by anion-exchange high-pressure liq-
uid chromatography (HPLC) against known standards. Com-
pared to Ajuba null-cells, Ajuba immunoprecipitated from
Ajuba-rescued Ajuba-null cells produced a small amount of
PI(4,5)P2 when incubated with PI(4)P (Fig. 2B, left panel).
When cells were incubated with PI(5)P as substrate, there was
little, if any, PI(4,5)P2 synthesized (data not shown). When PIP
kinase assays were performed on Ajuba immunoprecipitates
from cells stimulated to migrate, a significant increase in PIPK
type I activity was detected (Fig. 2B, right panel). Again little
PIPK type II activity was detected in stimulated cells (data not
shown). We did not detect any PI(3,4)P2 or PI(3,5)P2 pro-
duced, indicating that Ajuba did not interact with PI3K, an-
other phosphatidylinositol phosphate kinase capable of utiliz-
ing the same substrates.
Finally, to determine whether Ajuba and PIPKI associate
in cells expressing endogenous levels of each, we wounded wt
MEFs, added Ajuba antiserum or control nonspecific immu-
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noglobulin G (IgG) to total cell extracts, and then Western
blotted immunoprecipitated products for the presence of
PIPKI. Although control IgG immunoprecipitate contained a
small amount of PIPKI, there was a significant increase in the
amount of PIPKI present in the Ajuba immunoprecipitate
(Fig. 2C), indicating that PIPKI and Ajuba can associate in wt
MEFs stimulated to migrate (i.e., wounded).
These analyses indicated that PIPKI associated with Ajuba
in cells and that a migration stimulus significantly increased the
amount of PIPKI associated with Ajuba, signifying that the
FIG. 1. Mapping interaction of Ajuba and related LIM proteins with different PIPK enzymes. A to C. HEK 293 cells were cotransfected with
control empty vector (), Flag-Ajuba, Flag-PreLIM, or Flag-LIM regions of Ajuba and HA-tagged PIPK type I and I (A), PIPK type II and
II (B), or PIPK type I (C). Ajuba isoforms were immunoprecipitated with Flag antibodies, and bound products were Western blotted with HA
antibodies (i.e., PIPK, upper panels) and Flag antibodies (i.e., Ajuba, lower panels). A fraction (5%) of each cell lysate was Western blotted for
each protein (input). D. HEK 293 cells were cotransfected with HA-tagged PIPK enzymes and Myc-zyxin (upper two panels) or Myc-LPP (lower
two panels). PIPKs were immunoprecipitated with HA antibodies (left), and bound products were Western blotted with Myc antibodies (i.e., LIM
protein) and HA antibodies (i.e., PIPK enzyme). A fraction (5%) of each cell lysate was Western blotted for each protein (input).
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association between Ajuba and PIPKI was regulated, specifi-
cally by a migration stimulus.
Ajuba-null MEFs have decreased levels of intracellular
PI(4,5)P2. During cell migration lamellipodia are produced at
the leading edge, in the direction of migration. Lamellipodium
production results from local actin assembly, and thus, lamel-
lipodia are enriched for proteins and second messenger mol-
ecules important for the formation and disassembly of the
actin cytoskeleton (31). In light of Ajuba’s association with
PIPK enzymes and defective migration of Ajuba/ cells (32),
we asked whether there were differences in phosphatidylinosit-
ide levels in Ajuba/ MEFs in response to migration stimuli.
To address this, we employed two approaches. In the first
approach we made use of a recently described assay to isolate
lamellipodia (pseudopodia) from the remaining cell body (9,
32). Serum-starved early-passage Ajuba/ MEFs and control
wt littermate MEFs were incubated with inorganic 32Pi, and
then cells were seeded into the upper chamber of a well con-
taining fibronectin-coated filters (both sides) with 3-m pores.
Cell migration was stimulated by the addition of medium con-
taining 10% fetal calf serum to the lower chamber. After 90
min lamellipodia were isolated from the bottom of the filters
while the cell body fraction remained on the upper surface.
Total phosphoinositol lipids were extracted from each fraction,
deacylated, and then separated by anion-exchange HPLC
against known standards (Fig. 3A). Since Ajuba/ MEFs pro-
duce less lamellipodia than do wt MEFs (32), all samples were
first normalized by protein levels prior to loading on HPLC.
Compared to wt MEFs, both lamellipodia and cell body frac-
tions from Ajuba/ cells had decreased levels of PI(4,5)P2
and increased levels of PI(4)P (Fig. 3A and B). The difference
between cells for the two products appeared to be somewhat
greater in lamellipodia than in the cell bodies (Fig. 3A and B).
Compared to wt MEFs, the level of PI(4,5)P2 in Ajuba/
lamellipodia was reduced on average by 14%, whereas the level
of substrate PI(4)P was 40% higher (Fig. 3B). In the cell body
of Ajuba/ MEFs the PI(4,5)P2 level was reduced 10%, while
the level of PI(4)P substrate was increased 25% (Fig. 3B).
In the second approach PI(4,5)P2 levels in live, migrating
Ajuba/ and control wt MEFs were measured. Cells were
transiently transfected with a plasmid expressing the PH do-
main of phospholipase C (PLC) fused to GFP. The GFP-
PLC PH domain specifically interacts with PI(4,5)P2 in cells
(i.e., a PIP2 sensor) (12). To ensure that cells across experi-
mental groups expressed equivalent amounts of GFP-PLC
PH, red fluorescent protein (RFP) was cotransfected with
GFP-PLC PH (1:1 ratio) and only cells with equivalent levels
of RFP were compared. Following transfection, cells were in-
duced to migrate by making scratch wounds on a plate of
confluent cells and fluorescent video microscopy of live migrat-
ing cells at the wound edge was performed (Fig. 4A and B; see
also movies S1 and S2 in the supplemental material). The most
FIG. 2. PIPKI associates with Ajuba in cells, and migration stimuli increase this interaction. Ajuba (anti-Flag) was immunoprecipitated from
Ajuba-null MEFs (/), wild-type MEFs (wt), and Ajuba-null MEFs rescued with Flag-Ajuba (/, A). An aliquot of the immunoprecipitated
products was Western blotted for endogenous PIPKI (upper panels) or Ajuba (anti-Ajuba antibodies, lower panels). A fraction (5%) of each
lysate was also Western blotted for each protein (input). The left set of panels are immunoprecipitates from cells growing at steady state. The right
set of panels are immunoprecipitates from cells stimulated to migrate by scratch wounding. The ratio of PIPKI to Ajuba in the Ajuba
immunoprecipitate under each condition, as determined by densitometry, is listed below the respective lanes. B. The remainder of the same Ajuba
immunoprecipitate as in panel A was subjected to in vitro PIP kinase reaction, in the presence of [32P]ATP and PI(4)P as substrate. The left panel
is an immunoprecipitate from cells growing at steady state. The right panel is an immunoprecipitate from cells stimulated to migrate by scratch
wounding. C. wt MEFs were scratch wounded, as above, and lysed. Control IgG or Ajuba antiserum was added, and immunoprecipitates were
Western blotted for the presence of PIPKI (left panel). The right panels are input controls for the levels of PIPKI, Ajuba, and actin in the
respective cell lysates.
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striking difference between Ajuba/ and wt cells was the
reduction in GFP-PLC PH fluorescence in Ajuba/ MEFs.
In wt MEFs GFP-PLC PH accumulated throughout the ex-
tended lamellipodia in the direction of migration (Fig. 4A; see
also movie S1 in the supplemental material). The highest con-
centration of probe was detected in the membrane ruffles
formed at the leading edge of the lamellipodia (Fig. 4A, ar-
rowheads). During migration, cells maintained a gradient of
PIP2 from the lamellipodia facing the wound to the back of the
cell opposite the extending lamellipodia. GFP-PLC PH also
accumulated at the back of the cell preceding retraction of the
trailing tail (Fig. 4A, arrow). This tail accumulation of GFP-
PLC PH was not due to the bulging of the backside of a cell,
as the RFP intensity (indicative of cell volume) did not in-
crease over the same time period. In contrast to wt MEFs,
Ajuba/ MEFs did not migrate effectively into the wound, did
not produce broad lamellipodia, and displayed reduced mem-
brane ruffle formation (32; also data not shown). Localization
of GFP-PLC PH to the leading lamellipodia was reduced and
was evident in membrane ruffles only transiently and at low
levels (Fig. 4B, arrowheads; see also movie S2 in the supple-
mental material). Compared to the gradual gradient of GFP-
PLC PH from the leading edge to the rear of the cell in wt
MEFs, in Ajuba/ MEFs the GFP-PLC PH gradient was not
maintained, and we did not detect any accumulation of GFP-
PLC PH in the tail region (Fig. 4B, arrows; see also movie S2
in the supplemental material).
To ensure that the abnormal GFP-PLC PH staining profile
in migrating Ajuba/ MEFs was due to the absence of Ajuba,
Ajuba/ MEFs were transiently transfected with GFP-PLC
PH and RFP-Ajuba or as a control GFP-PLC PH and RFP
alone. RFP-Ajuba rescued the motility defect of Ajuba/
cells, as expected (32). Coexpression of Ajuba and GFP-PLC
PH in Ajuba/ cells resulted in a GFP-PLC PH staining
profile similar to that of wt cells, including enrichment in lead-
ing-edge lamellipodia, accumulation in membrane ruffles (Fig.
4C, arrowheads; see also movie S3 in the supplemental mate-
rial), and accumulation in the tail preceding retraction (Fig.
4C, arrow; see also movie S3 in the supplemental material).
In summary, by two different methods, Ajuba/ MEFs
were found to contain reduced levels of PI(4,5)P2 and in-
creased levels of PI(4)P compared to wt MEFs, particularly in
the lamellipodia and membrane ruffles at the leading edge of
migrating cells. Reintroduction of Ajuba into these cells res-
cued not only the migration defect but also the level of
PI(4,5)P2. This reduction in PI(4,5)P2 level and corresponding
increase in PI(4)P level in Ajuba/ MEFs suggested that
synthesis of PI(4,5)P2 could be regulated by Ajuba in these
cells.
FIG. 3. Ajuba-null MEFs have decreased levels of PI(4,5)P2 and increased levels of PI(4)P. A. Wild-type (/) or Ajuba-null (/) MEFs
were incubated with 32Pi. Cellular lipids were isolated from lamellipodia and cell bodies of migrating cells, as described in Materials and Methods.
Representative HPLC chromatograms of lamellipodium (upper panels) and cell body (lower panels) fractions are shown. B. From multiple
experiments, incorporated 32P counts were quantified at each peak and presented as the mean and standard deviation about the mean. Gray
columns, Ajuba/; black columns, wild type (/).
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Ajuba influences the membrane localization of PIPKI and
enhances PIPKI enzymatic activity while inhibiting PIPKII
activity in vitro. Ajuba could regulate PI(4,5)P2 synthesis by
influencing the localization of PIPK enzymes, PIPK enzyme
activity, or both. To determine if Ajuba influenced enzyme
localization, wt and Ajuba-null MEFs were induced to migrate,
by scratch wounding, and after a period of time fixed, and
indirect immunofluorescence with antiserum that detects en-
dogenous PIPKI (15) was performed. In wild-type MEFs
PIPKI was localized to the leading-edge membrane ruffles
and nucleus and diffusely throughout the cytoplasm, as ex-
pected (Fig. 5A and C) (15). However, in Ajuba-null MEFs
there was little PIPKI detected at the leading edge (Fig. 5B
and D). It should be noted that migrating Ajuba-null cells
produced less membrane ruffles at the leading edge than did
migrating wild-type cells. In Ajuba-null cells PIPKI was still
detected in the nucleus and cytosol, however. When migrating
Flag-Ajuba-rescued Ajuba-null cells were costained for
PIPKI (anti-PIPKI antibody) and Ajuba (anti-Flag anti-
body), we did not detect significant colocalization of these two
proteins (data not shown).
FIG. 4. Migrating Ajuba-null MEFs have decreased levels of PI(4,5)P2, as detected by the PI(4,5)P2 sensor GFP-PLC PH. Wild-type (/)
MEFs (A) or Ajuba-null (/) MEFs (B) were transfected with GFP-PLC PH, and scratch wounds were made. Migration into the wound is
towards the right. Time-lapse frames (minutes) acquired during migration show the fluorescence intensity of the GFP-PLC PH probe. Pseudo-
colors reflect the fluorescent intensity from low (blue) to high (red). Arrowheads identify membrane ruffles at the leading edge. Arrows identify
the retracting tail. C. Wild-type MEFs (/) were transfected with GFP-PLC PH probe (left panel), Ajuba-null MEFs (/) were cotransfected
with the GFP-PLC PH probe and RFP (middle panel), and Ajuba-null MEFs were cotransfected with GFP-PLC PH probe and RFP-Ajuba
(right panel). Migration was stimulated by scratch wounding cells, and cell migration into the wound (towards the right) was imaged. Arrowheads
identify membrane ruffles at the leading edge. Arrows identify the retracting tail.
FIG. 5. PIPKI localization to the leading-edge membrane ruffles
is decreased in migrating Ajuba-null MEFs. Wild-type (A and C) or
Ajuba/ (B and D) MEFs were stimulated to migrate by scratch
wounding and then fixed, and an immunofluorescence assay with an
antibody that detects endogenous PIPKI was performed. The direc-
tion of migration is towards the top of the page. Arrows identify
membrane ruffles at the leading edge.
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These results suggested the possibility that Ajuba is required
for the leading-edge membrane ruffle localization of PIPKI.
In addition, the diminution of leading-edge membrane ruffling
in migrating Ajuba-null cells could also be contributing to the
decreased PIPKI staining observed at this site.
To determine whether Ajuba’s interaction with PIPKs influ-
enced their enzymatic activity, purified PIPKI, PIPKII, and
PIPKII were mixed with the purified PreLIM region of
Ajuba. His-tagged PIPKs and GST-PreLIM Ajuba were ex-
pressed and purified from Escherichia coli as described previ-
ously (16, 45). The purity of the isolated proteins is shown in
Fig. 6A. In the presence of substrate and [32P]ATP all purified
enzymes were active (data not shown). The PreLIM region of
Ajuba was used rather than full-length Ajuba, as expression of
GST-Ajuba was not stable in bacteria, and purification resulted
in multiple degradation products, thereby decreasing the ef-
fective concentration of binding domain in the sample.
In the presence of fixed amounts of PIPKI enzyme and
PI(4)P substrate the addition of increasing amounts of Ajuba
PreLIM peptide to the kinase reaction resulted in enzyme
activation [i.e., increased PI(4,5)P2 production] (data not
shown). When the amounts of PreLIM peptide and PI(4)P
substrate were fixed, increasing amounts of added PIPKI also
resulted in increased PI(4,5)P2 synthesis (data not shown). A
maximum sixfold stimulation of the PIPKI kinase activity was
observed in the presence of a 30-fold molar excess of Ajuba
PreLIM peptide (Fig. 6B). This stimulation was specific to
Ajuba PreLIM peptide, as the addition of an equal amount of
unrelated protein, such as bovine serum albumin (BSA) or
GST, had no effect (Fig. 6B).
Interestingly, Ajuba PreLIM peptide had the opposite effect
on the kinase activity of PIPKII. In the presence of fixed
amounts of PIPKII and PI(5)P substrate the addition of in-
creasing amounts of Ajuba PreLIM peptide inhibited the pro-
duction of PI(4,5)P2 (Fig. 6C). At the same 30-fold molar
excess of PreLIM peptide PIPKII activity was inhibited four-
to fivefold (Fig. 6C). Importantly the addition of Ajuba Pre-
LIM peptide to PIPKII, an enzyme that did not interact with
Ajuba, had no effect on its kinase activity (Fig. 6D). Thus,
Ajuba profoundly increased the activity of PIPKI while in-
hibiting the activity of PIPKII, in vitro.
PIPKI is required for fibroblast migration. Since Ajuba
can influence the activity of PIPKI and Ajuba-null cells have
decreased amounts of PI(4,5)P2 and are inhibited in their cell
migration, we determined whether PIPKI was required for
the migration of wt MEFs. To do so, PIPKI levels were
reduced using an RNAi strategy. Primary wt MEFs were in-
fected with retroviruses expressing an siRNA against PIPKI
or as a control a scrambled siRNA. The time to significant
reduction in PIPKI protein level following RNAi treatment
FIG. 6. Ajuba activates PIPKI activity but inhibits PIPKII activity, in vitro. A. Coomassie blue-stained SDS-polyacrylamide gel electro-
phoresis of an aliquot of purified PIPKs and PreLIM Ajuba peptide. For comparison 1 g of BSA was run in lane 6. Dots identify enzymes or
PreLIM peptide. Molecular standards in kDa are run in lane 1. B. In vitro kinase activity of PIPKI in the presence of a 30-fold excess of PreLIM
Ajuba peptide or control BSA or GST. Fold increase in enzyme activity is presented below each lane (control, no additions, lane 1 	 1). C. In vitro
kinase activity of PIPKII in the presence of fixed amounts of PIPKII and increasing amounts of PreLIM Ajuba peptide. Fold decrease in enzyme
activity is presented below each lane (control, no additions, lane 1 	 1). D. In vitro kinase activity of PIPKII in the presence of fixed amounts
of PIPKII and increasing amounts of PreLIM Ajuba peptide. Fold change in enzyme activity is presented below each lane (control, no additions,
lane 1 	 1).
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was relatively long. The level of PIPKI did not begin to
significantly decrease until day 5 (Fig. 7A). In control scram-
bled RNAi-treated MEFs we did not observe any decrease in
PIPKI level at day 5 (Fig. 7A). The level of the focal adhesion
protein vinculin was not changed in PIPKI siRNA or control
scrambled siRNA-treated cells (data not shown). Interestingly
at 7 or more days following RNAi infection the PIPKI levels
further dropped and cells began to die. Similar results were
observed in PIPKI siRNA-treated HEK293 cells. Cell viabil-
ity appeared to depend upon the degree of PIPKI protein
reduction. High-level PIPKI knockdown resulted in cell
death, whereas cells with partial knockdown remained viable
for longer periods. Thus, for migration assays, we analyzed
MEFs with approximately a 50 to 60% decrease in PIPKI
protein level (e.g., day 5). When control scrambled siRNA-
treated MEFs and PIPKI siRNA-treated MEFs were induced
to migrate, by scratch wounding, cells containing reduced lev-
els of PIPKI were inhibited in their migration (Fig. 7B and
C). Scrambled siRNA-treated wt MEFs migrated at the same
rate as untreated wt MEFs (data not shown). This result sug-
gested that PIPKI is important for an appropriate cell migra-
tion response; however, some caution is necessary, as PIPKI
knocked-down cells began to die 2 days after these migration
assays were performed.
DISCUSSION
Here we show that the LIM protein Ajuba specifically reg-
ulates cellular PI(4,5)P2 levels by directly interacting with and
activating PIPKI to increase synthesis of PI(4,5)P2 from
PI(4)P. Migration stimulus significantly increased the amount
of PIPKI associated with Ajuba, indicating that the interac-
tion is regulated. In the absence of Ajuba protein migrating
MEFs are defective in production of PI(4,5)P2 and have a
corresponding increase in PI(4)P substrate. Reintroduction of
Ajuba into Ajuba/ MEFs corrects both PI(4,5)P2 levels and
cell migration. In the absence of Ajuba PIPKI does not lo-
calize appropriately to membrane ruffles at the leading edge of
migrating cells and the level of PI(4,5)P2 in lamellipodia is also
decreased. In vitro, Ajuba was found to be a potent activator of
PIPKI enzyme activity while inhibiting PIPKII activity.
Ajuba/ MEFS are inhibited in their migration and have
been shown to be defective in activating Rac1 in response to
migratory cues (32). Rho family GTPases, including Rac1,
have been shown to bind to PIPKs, including PIPKI, and
influence their activity. In many situations PIPKI appears to
be a downstream effector of Rac1 signaling (8, 20, 40). Alter-
natively, the association of PIPKI with active Rac1 can influ-
ence enzyme recruitment to membranes. Although PIPKI
and Rac1 activities cooperate to regulate membrane ruffling,
for example, each protein also has independent functions in
the production of membrane ruffles during migration (15).
Since Ajuba positively influences Rac1 activity during migra-
tion, it is likely that Ajuba-dependent Rac1 activation also
contributes to the activation of PIPKI and thus PI(4,5)P2
production during migration. However, we have shown that
Ajuba directly interacts with PIPKI and that this association
is increased following migration stimuli and can affect PIPKI
enzyme activity independently of Rac1, suggesting that Ajuba
may also regulate PI(4,5)P2 levels and migration by directly
activating PIPKI. PIPKI is required for proper cell migra-
tion, as siRNA-mediated knockdown of PIPKI in wild-type
MEFs inhibited their migration. Future work is directed at
distinguishing the contribution of Ajuba’s effect upon Rac1 to
PIPKI activity from Ajuba’s direct effects upon PIPKI. Re-
gardless, both these effects of Ajuba contribute to the produc-
tion of PI(4,5)P2 and thus enhanced migratory responses
through modulation of the actin cytoskeleton. Since PIPKI
can also be a downstream effector of another G protein, Arf6,
in membrane ruffle formation (20), this raises the possibility
that Ajuba might also influence Arf6 activity.
Ajuba appeared to be necessary for the proper localization
of PIPKI to membrane ruffles at the leading edge of migrat-
ing cells. Despite this alteration in enzyme localization and the
ability to coimmunoprecipitate Ajuba and PIPKI, we were
not able to colocalize these two proteins by immunofluores-
cence analysis of fixed and live migrating cells. This could be
due to a number of possibilities. In cells Ajuba is present at
focal adhesions and diffusely in the cytosol and shuttles in and
out of the nucleus. It is not present at the leading edge of
migrating cells or in membrane ruffles (where PIPKI local-
izes). Therefore, Ajuba and PIPKI may be interacting in
other cellular compartments and Ajuba’s role is to deliver the
enzyme to sites of membrane ruffling, much like the proposed
role for Ajuba in delivering p130Cas to nascent focal com-
plexes in migrating cells (32). In support of this possibility we
have recently observed Ajuba on motile cytosolic vesicles, and
these appear to shuttle to and from the leading edge of mi-
grating cells (S. Pratt and G. Longmore, unpublished). Fur-
FIG. 7. PIPKI is required for fibroblast migration. (A) wt MEFs
were infected with lentiviruses expressing a PIPKI-specific siRNA or
scrambled control (Scr.), and on the indicated days postinfection cell
lysates were immunoblotted for PIPKI and actin. The amount of
PIPKI present on day 5, relative to day 0, is listed below the day 5
lanes. (B and C) Confluent plates of wt MEFs 5 days after infection
with control scrambled siRNA (B) or PIPKI-specific siRNA (C) were
scratch wounded, and 10 h later differential interference contrast im-
ages of wound closure were obtained. The direction of migration is
towards the bottom of the page.
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thermore, Ajuba’s recruitment to adhesive complexes in fibro-
blasts and epithelial cells is regulated (S. Pratt and G.
Longmore, unpublished; 27). The LIM region of Ajuba directs
its localization to adhesive complexes in both cell types, while
the PreLIM region directs Ajuba’s association with PIPKI
and activates its enzyme activity. Accumulating evidence indi-
cates that the LIM region and PreLIM region of this family of
LIM proteins have distinct target interactions, suggesting that
a possible role for these proteins is to couple different intra-
cellular signaling pathways or functions in response to a stim-
ulus. For example, Ajuba contributes to the function of adhe-
rens junctions in epithelial cells by coupling epithelial cell-cell
junctions to the actin cytoskeleton through a LIM region in-
teraction with -catenin bound to E-cadherin and a PreLIM
interaction with F-actin (27) or the recruitment of p130Cas to
focal adhesions through its interaction with Ajuba’s PreLIM
region while the LIM region of Ajuba targets this protein
complex to nascent adhesive complexes in migrating cells (32).
The decreased PIPKI localization to the leading edge of
Ajuba-null cells may also reflect the decrease in membrane
ruffling apparent in Ajuba-null cells. Only the PIPKI PIPK
isoform localizes to membrane ruffles, and expression of a
kinase-dead mutant of PIPKI blocks membrane ruffling (15).
When overexpressed PIPKI did not stimulate membrane ruf-
fles, however, in the presence of constitutively activated Rac,
membrane ruffles were produced. These authors proposed that
PIPKI regulates localized production of PI(4,5)P2 while ac-
tual membrane ruffle formation requires Rac activation. Ajuba
may provide a link between these two pathways to regulate
membrane ruffling.
Although Ajuba and related LIM proteins are present at
focal adhesions (5, 32), Ajuba did not interact with PIPKI
(the type I PIPK isoform present at focal adhesions). Talin,
another focal adhesion protein, was shown to localize PIPKI
to focal adhesions and activate its enzymatic activity at these
sites, thereby regulating focal adhesion formation (13, 26). The
subcellular distribution of the zyxin/Ajuba family of LIM pro-
teins is largely overlapping, and yet related LPP and zyxin did
not interact with the PIPKs, suggesting some structural feature
unique to Ajuba vis-a`-vis an association with PIPK. The N-
terminal PreLIM regions of this protein family are the most
divergent, and with respect to Ajuba, PIPKI, and PIPKI this
was the region that directed the association.
The zyxin/Ajuba LIM proteins also contain nuclear export
sequences in their PreLIM regions, and multiple studies have
demonstrated that they shuttle in and out of the nucleus (23,
29, 30), and nuclear accumulation of Ajuba in embryonal car-
cinoma cells has been shown to affect cell proliferation and cell
fate decisions, through pathways that are presently undeter-
mined (23). Phosphoinositides are also present in the nucleus,
and their composition varies during the cell cycle (10, 22).
Endogenous PIPKI has been shown to localize to the nucleus
in a speckled pattern, where it is thought to function in mRNA
processing (14). Whether Ajuba also interacts with PIPKI in
the nucleus and could influence phosphoinositide regulation in
the nucleus remains to be determined.
How an association with Ajuba can have different effects
upon two related PIPK enzymes is unclear. Ajuba profoundly
increases the activity of PIPKI while inhibiting the activity of
PIPKII, in vitro. The sequences of various PIPK isoforms are
quite conserved, and yet it is not clear how their activity and
PI(4,5)P2 synthesis are regulated (25). Nevertheless, since
PI(4)P is the major PIP present in cells, the physiological
significance of inhibiting PIPKII activity is likely to be of
minimal importance. This would appear to be true, as in vivo
Ajuba’s effect upon PIPKI clearly predominates, since the
levels of PI(4,5)P2 are decreased in Ajuba/ cells, while if its
inhibitory effect upon PIPKII predominated, they would be
increased.
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